Eledon Pharmaceuticals
ELDN
ELDN
15 hedge funds and large institutions have $15M invested in Eledon Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$661K | |
| 2 | +$110K | |
| 3 | +$53K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$24.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.9K |
Top Sellers
| 1 | -$145K | |
| 2 | -$76K | |
| 3 | -$9.11K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3K |
| 5 |
BlackRock
New York
|
-$2.82K |